Humacyte, Inc. HUMA
0.44 USD +0.04 (+10.65%)
At closeNov 4, 2026, 4:43 AM EST
0.43 -0.01 -2.38%
Pre-market · Nov 4, 4:43 AM ET
0.391 Day range 0.4452
0.337 52-week range 1.56
- YTD
- -54.16%
- 1 year
- -72.30%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 13.71 +3013.3% upside
Now 0.4405
- Target (low)
- 6.00
- Target (mean)
- 13.71
- Target (high)
- 25.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
- Strong buy1
- Buy5
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 6
- 3 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.2575 | -0.31 – -0.22 | -0.2586 | +0.4% | 0 | 0.0% | 4 |
| Next quarter | -0.245 | -0.27 – -0.22 | -0.2522 | +2.8% | 2.37M | 0.0% | 2 |
| Current year | -1.28 | -1.41 – -0.99 | -0.9742 | -30.9% | 214.29K | 0.0% | 4 |
| Next year | -0.84 | -1.03 – -0.68 | -1.28 | +34.1% | 12.19M | +5587.5% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 23, 2024 | Benchmark | Maintained | Buy | Buy |
| Dec 20, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Dec 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 21, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 11, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 28, 2024 | EF Hutton | Maintained | Buy | Buy |
| Oct 18, 2024 | TD Cowen | Reiterated | Buy | Buy |
| Oct 18, 2024 | BTIG | Reiterated | Buy | Buy |
| Oct 10, 2024 | Benchmark | Reiterated | Buy | Buy |
| Oct 1, 2024 | EF Hutton | Maintained | Buy | Buy |
| Sep 20, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Sep 9, 2024 | EF Hutton | Initiated | — | Buy |
| Sep 5, 2024 | Benchmark | Reiterated | Buy | Buy |
| Aug 14, 2024 | Benchmark | Reiterated | Buy | Buy |
| Aug 12, 2024 | Benchmark | Reiterated | Buy | Buy |
| Jul 15, 2024 | BTIG | Maintained | Buy | Buy |
| Jul 2, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jul 2, 2024 | Benchmark | Reiterated | Buy | Buy |
| May 24, 2024 | Benchmark | Reiterated | Buy | Buy |
| May 13, 2024 | Benchmark | Reiterated | Buy | Buy |
| Apr 1, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 26, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Mar 25, 2024 | Benchmark | Reiterated | Buy | Buy |
| Mar 8, 2024 | Piper Sandler | Maintained | Neutral | Neutral |
| Dec 27, 2023 | Benchmark | Maintained | Buy | Buy |
| Dec 11, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 10, 2023 | Piper Sandler | Maintained | Neutral | Neutral |
